SGLT2 inhibitor alleviates hypomagnesemia in patients with chronic kidney disease: a retrospective observational study

被引：0
|
作者：
Osawa, Kosuke [1 ]
Ohya, Masaki [2 ]
Yamamoto, Shuto [2 ]
Nakashima, Yuri [2 ]
Tanaka, Yusuke [2 ]
Yamano, Yukiko [2 ]
Takatsuka, Taisuke [2 ]
Araki, Shin-Ichi [2 ]
机构：
[1] Wakayama Med Univ, Dept Nephrol, Wakayama, Japan
[2] Wakayama Med Univ, Sch Med, Dept Nephrol, Wakayama, Japan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
10.1093/ndt/gfae069.1220
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
646
引用
收藏
页数：2
相关论文
共 50 条
  • [1] SGLT2 inhibitor alleviates hypomagnesemia in patients with chronic kidney disease: a retrospective observational study
    Osawa, Kosuke
    Ohya, Masaki
    Yamamoto, Shuto
    Nakashima, Yuri
    Tanaka, Yusuke
    Yamano, Yukiko
    Takatsuka, Taisuke
    Araki, Shin-Ichi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1976 - I1977
  • [2] SGLT2 Inhibitors Decrease Overhydration and Proteasuria in Patients with Chronic Kidney Disease: A Longitudinal Observational Study
    Schork, Anja
    Eberbach, Marie-Luise
    Bohnert, Bernhard N.
    Woern, Matthias
    Heister, David J.
    Eisinger, Felix
    Vogel, Elisabeth
    Heyne, Nils
    Birkenfeld, Andreas L.
    Artunc, Ferruh
    KIDNEY & BLOOD PRESSURE RESEARCH, 2024, 49 (01): : 124 - 134
  • [3] SGLT2 Inhibitors and Kidney Outcomes in Patients with Chronic Kidney Disease
    Kanduri, Swetha R.
    Kovvuru, Karthik
    Hansrivijit, Panupong
    Thongprayoon, Charat
    Vallabhajosyula, Saraschandra
    Pivovarova, Aleksandra I.
    Chewcharat, Api
    Garla, Vishnu
    Medaura, Juan
    Cheungpasitporn, Wisit
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09)
  • [4] SGLT2 Inhibitor Use in Chronic Kidney Disease: Supporting Cardiovascular, Kidney, and Metabolic Health
    Madero, Magdalena
    Chertow, Glenn M.
    Mark, Patrick B.
    KIDNEY MEDICINE, 2024, 6 (08)
  • [5] SGLT2 inhibitors for treatment of chronic kidney disease
    Davis, S.
    SA PHARMACEUTICAL JOURNAL, 2024, 91 (02) : 26 - 28
  • [6] SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease
    Tuttle, Katherine R.
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (06): : 414 - 415
  • [7] PRESCRIPTION OF SGLT2 INHIBITORS TO PATIENTS WITH CHRONIC KIDNEY DISEASE: A QUALITATIVE STUDY OF NEPHROLOGISTS AND CARDIOLOGISTS
    Milder, Tamara
    Stocker, Sophie
    Baysari, Melissa
    Day, Richard
    Greenfield, Jerry
    NEPHROLOGY, 2022, 27 : 74 - 74
  • [8] Cardiovascular outcomes and safety of SGLT2 inhibitors in chronic kidney disease patients
    Chen, Xiutian
    Wang, Jiali
    Lin, Yongda
    Yao, Kaijin
    Xie, Yina
    Zhou, Tianbiao
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [9] Mineralocorticoid Receptor Antagonist Combined with SGLT2 Inhibitor versus SGLT2 Inhibitor Alone in Chronic Kidney Disease: A Meta-Analysis of Randomized Trials
    Ferreira, Joao Pedro
    Oliveira, Ana Cristina
    Vasques-Novoa, Francisco
    Leite, Ana Rita
    Mendonca, Luis
    Zannad, Faiez
    Butler, Javed
    Leite-Moreira, Adelino
    Saraiva, Francisca
    Neves, Joao Sergio
    AMERICAN JOURNAL OF NEPHROLOGY, 2024,
  • [10] SGLT2 Inhibitors slow the Progression of chronic Kidney Disease
    不详
    DIABETOLOGE, 2019, 15 (06): : 567 - 567
12345